Recent Updates
Recently added Catalysts

Upcoming Catalyst

Drug Pipeline Intelligence

Clinical Trial Results

Inside Trades

Options Data

News Section

Hedge Funds

Ownership Trends

Competitive Position

HOOKIPA Pharma Inc.

$1.13

+0.01 (+0.48%)

C 41Pipeline Score Undervalued Biotech · Clinical
Market Cap
10.25 M
EPS
-5.93
P/E Ratio
-
Value Trade
10.64 K
SEC Financials
Q1 2025

  • Dilution Risk

    5%

  • Revenue

    2.00 M

  • R&D Expenses

    12.86 M

  • Operating CF

    52.00 K

  • Total Assets

    61.26 M

  • Total Liabilities

    27.18 M

  • Equity

    34.08 M

  • D/E Ratio

    12,345

-6.63 %
Week
-26.93 %
1 Month
-43.6 %
3 Month
-55.3 %
6 Month
-99.21 %
5 Year
-99.41 %
All Time
Cash Data
Profitable

  • Cash Position

    40.28 M

  • Monthly Burn

    -

  • Runway

    12,345 mo

  • Burn Trend

    Decelerating

  • SEC Filing

    May 15, 2025
Overview
Volume
9.27 K
52 Week Range
0.72 - 5.66
% held by Insiders
42.75 %
% held by Institutions
20.2 %
Enterprise Value
-29.53 M
Total Shares
9.80 M
Short %
1.87 %
Float Shares
6.85 M
Company Description
Founded:2019

locked

Upcoming Catalyst
Catalyst Drug/Treatment Stage Probability of Approval Description Drug Type Therapeutic Area Source
Interim Results example
HB-700 multi-KRAS targeting immunotherapy
Phase 1
—
Nanomedicine
Oncology
HB-700 multi-KRAS targeting immunotherapy
Phase 1
—
Nanomedicine
Oncology
HB-700 multi-KRAS targeting immunotherapy
Phase 1
—
Nanomedicine
Oncology
Unlock Upcoming Catalyst data
Drug Pipeline Intelligence
C41
Pipeline Score
$110M
Pipeline Value
Undervalued
Valuation Signal
3
Drugs Scored
10.7x
rNPV / MCap
Top 60%
Micro Cap
(rank 363 of 905)
Percentile Rank
HOOKIPA Pharma Inc. carries a moderate pipeline score (41/100), with $441M risk-adjusted pipeline value, led by HB-101 vaccine in Cytomegalovirus (CMV) Infection (Phase 2).
Showing 1 of 1 assets
DrugIndicationPhaseNCT IDPTRSrNPVStatusEnrollmentVelocityDesignCompletionML SignalLast Change
HB-101 vaccine
Monoclonal antibody		Cytomegalovirus (CMV) InfectionPhase 2NCT0362908023% $258M COMPLETED 83 - -Jun 22, 2022 -Oct 26, 2023
Unlock Drug Pipeline Intelligence
Clinical Trial Results
Drug Name Indications Phase Date Trial Results Summary Title Source
Example Drug
Example indication for clinical evaluation
Phase 3
2025-12-01
Example Drug
Example indication for clinical evaluation
Phase 3
2025-12-01
Example Drug
Example indication for clinical evaluation
Phase 3
2025-12-01
Unlock Clinical Trial Results data
Inside Trades
TREND
CORPORATE INSIDERS BOUGHT SHARES WORTH 1.8M IN THE LAST 3 MONTHS
YEARLY INSIDER TRANSACTIONS
Sector Avg.
INSIDERS
SOLDINSIDERS
BOUGHT
POSITIVE SENTIMENT Based on 22 Insiders Transactions
Unlock Inside Trades data
Show Data
Hedge Funds
TREND
HEDGE FUNDS INCREASED HOLDINGS BY 200.0K SHARES IN THE LAST QUARTER
Shares Held
2040.00B1530.00B1020.00B510.00B0
Q3
2024
Q4
2024
Q1
2025
Q2
2025
HEDGE FUNDS
SOLDHEDGE FUNDS
BOUGHT
POSITIVE SENTIMENT Based on 27 hedge funds in the last quarter
18 buying (3 new)·9 selling (1 exited)·2 unchanged
Fund Count
60%
Share Volume
25%
Conviction
15%
Hedge Funds invested in HOOK
HedgeFund Name
( 3 )
% of Portfolio Current MV
-
Shares Owned
-
Activity
Avg Price $0

Example Capital Management

2.5 %
15.00 M
250.00 K

Example Capital Management

2.5 %
15.00 M
250.00 K

Example Capital Management

2.5 %
15.00 M
250.00 K
Unlock Hedge Funds table data
HOOKIPA Pharma Inc. (HOOK) Analyst Ratings & Price Targets
Symbol
Firm
Rating
Action
Price Target
Upside
date
HOOK
Example Securities
Buy
Initiated
$150.00
+25%
2026-01-15
HOOK
Example Securities
Buy
Initiated
$150.00
+25%
2026-01-15
HOOK
Example Securities
Buy
Initiated
$150.00
+25%
2026-01-15
Unlock Biotech Analyst Ratings data
HOOK Stock Forecast & Analyst Consensus
BUY
Analyst Ratings
Buy65.0%
Hold25.0%
Sell10.0%
Price Target Trend
Average$24.00
Low$18.00
High$32.00
Unlock Price Target Trend
HOOK Institutional Ownership Trends
Current Insider %
5.20%
—+0.00%
Current Institutional %
62.40%
—+0.00%
Total Ownership
67.60%
Insider + Institutional
Data Points
1
1 Ticker(s)
Option Chain Statistics
ExpirationVolumeOpen InterestImplied Volatility CallsImplied Volatility Puts
CallsPutsPut-Call RatioCallsPutsPut-Call RatioIVOiWaIvVWaIvIVOiWaIvVWaIv
2027-01-15 0.00 0 - - - - - -
2027-01-15 0.00 0 - - - - - -
2027-01-15 0.00 0 - - - - - -
Unlock Option Chain Statistics data
Option Chain
CallsStrikePuts
Last PriceVolumeOpen InterestLast PriceVolumeOpen Interest
No data available
Unlock Option Chain data
Unlock Options Chart data
Open interest
0 600K 1.2M 1.8M Avg OI 1.00 M Open Interest
0 1 2 3 1.1 Put-Call Ratio
Today's Open Interest
1.00 M
Put-Call Ratio
1.1
Put Open Interest
480.00 K
Call Open Interest
520.00 K
Open Interest Avg (30-day)
900,000
Today vs Open Interest Avg (30-day)
11.11%
Option Volume
0 450K 900K 1.4M Avg OV 750.00 K Option Volume
0 1 2 3 0.95 Put-Call Ratio
Today's Volume
750.00 K
Put-Call Ratio
0.95
Put Volume
360.00 K
Call Volume
390.00 K
Volume Avg (30-day)
800,000
Today vs Volume Avg (30-day)
-6.25%
Company News
Competitive Position
How HOOK ranks across every disease it competes in
Competitive Position is a premium feature
See how HOOK ranks against every competitor across each disease it develops in: phase, best drug, trials and likelihood of approval.
Start free trial